Category: Media

Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update

Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete

Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

Femasys Shareholder Update – Q1 2026

Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio

From Lab to Life the Journey Behind Solving Womens Healthcare

Intratubal insemination success, at age 39 – Aslyn’s story

Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth

Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update

Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors